Skip to main content
OpenTrials
Completed

NCT Number: NCT00525317

Does Oral Magnesium Substitution Relieve Pregnancy Induced Leg Cramps ?

This is a trial of treatment with tablets containing magnesium for leg cramps in pregnancy.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Healthy pregnant women between 18 and 36 weeks of pregnancy suffering from leg cramps at least twice a week were treated with magnesium tablets or placebo for two weeks, 120 mg x 3 daily.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pregnant women with recurrent leg cramps (at least twice a week).
  • No disease according to helath certificate. Written participation consent must be signed.
  • Linguistic ability demanded: Norwegian as the first language. Gestation length more than 17 weeks, less than 36 weeks.

Exclusion criteria

  • Twin pregnancy.
  • Oedema.
  • Pre-eclampsia.
  • Magnesium supplementation beyond the trial treatment.

Treatment and study plan

"Nycoplus Magnesium" (120 mg x 3 daily for 2 weeks)

Drug

120 mg x 3 or placebo

Other names: Nycoplus Magnesium tablets(R), Placebo tablets

Primary outcomes

  1. Pain intensity and frequency

    Time frame: end of study

Sponsors and collaborators

Lead sponsor

Oslo University Hospital

Other

Collaborators

  • Sykehuset Asker og Baerum
  • Takeda Nycomed

Registry information

Official study title

Does Oral Magnesium Substitution Relieve Magnesium Induced Leg Cramps ?

Important dates

Study start
2002
Primary completion
2004
Study completion
2004
First posted
Sep 5, 2007
Registry last updated
Dec 17, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.